Text Size

Interaction Between Genetic Factors and Maternal Stressors During Pregnancy in the Risk of Postpartum Depression (IGEDEPP)

This study is currently recruiting participants.
Verified January 2013 by Assistance Publique - Hôpitaux de Paris
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01648816
First received: July 20, 2012
Last updated: January 30, 2013
Last verified: January 2013
History of Changes
  Purpose

"The prevalence of postpartum depression (PPD) is approximately 13%. PPD is associated with a higher maternal morbidity and mortality, and also with pervasive effects on the emotional, cognitive and behavioral development of the infant.

Stressful life events, socio-demographic and obstetrical risk factors have been associated with the risk of PPD. Genetics risk factors of PPD have also been identified. We are presently studying for the first time how maternal stressors may interact with genetic factors to increase the risk of PPD (Gene x Environment interaction)".


Condition
Postpartum Depression

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Interaction Between Genetic Factors and Maternal Stressors During Pregnancy in the Risk of Postpartum Depression

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • Depressed subject at Week 8 and at 1 year (EPDS and DSM I-V criteria for depression [ Time Frame: 8 weeks-1 year ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 3000
Study Start Date: November 2011
Estimated Study Completion Date: November 2014
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
postpartum depression
caucasian mothers with postpartum depression
Postpartum depression

Detailed Description:

"The prevalence of postpartum depression (PPD) is approximately 13%. PPD is associated with a higher maternal morbidity and mortality, and also with pervasive effects on the emotional, cognitive and behavioral development of the infant.

Stressful life events, socio-demographic and obstetrical risk factors have been associated with the risk of PPD. Genetics risk factors of PPD have also been identified. We are presently studying for the first time how maternal stressors may interact with genetic factors to increase the risk of PPD (Gene x Environment interaction).

We want first to analyze the allelic association between SNPs of 5-HT, HPA and neurodevelopment genes and PPD with a case control association study We then analyse the interaction between maternal stressors during pregnancy and SNPS of our candidate genes (CRHR1, 5-HTT, TPH, BDNF, HMCN1).

3000 Caucasian mothers are included after pregnancy in 7 maternities and are evaluated at the inclusion, at 8 weeks and at 1 year with DIGS, FISC, EPDS and HAD, Stressful life events (Paykel). Blood are collected for all subjects for DNA extraction.

At week 8 and 1 year after pregnancy we search PPD with EDPS and DSM-IV criteria of depression".

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

causasian mothers after pregnancy

Criteria

Inclusion Criteria:

  • Caucasian mothers included after pregnancy (J0-J4)

Exclusion Criteria:

  • Age <18 years old, schizophrenia or mental retardation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01648816

Contacts
Contact: Caroline Dubertret, MD, PhD 00331 47 60 64 13 caroline.dubertret@lmr.aphp.fr

Locations
France
Louis Mourier Hospital Recruiting
Colombes, France, 92700
Contact: Caroline Dubertret, MD PhD     00331 47 60 64 13     caroline.dubertret@lmr.aphp.fr    
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Study Director: Caroline Dubertret, MD, PhD Assistance Publique - Hôpitaux de Paris
  More Information

No publications provided

Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT01648816     History of Changes
Other Study ID Numbers: AOM 10056, 2010-A01315-35
Study First Received: July 20, 2012
Last Updated: January 30, 2013
Health Authority: France: Ministry of Health

Additional relevant MeSH terms:
Depression
Depressive Disorder
Depression, Postpartum
Behavioral Symptoms
 Mood Disorders
Mental Disorders
Puerperal Disorders
Pregnancy Complications

ClinicalTrials.gov processed this record on May 19, 2013